  \textit{Plasmodium vivax} is the most geographically widespread
malaria-causing parasite resulting in significant associated global morbidity
and mortality. One of the factors driving this widespread phenomenon is the
ability of the parasites to remain dormant in the liver. Known as hypnozoites,
they reside in the liver following an initial exposure, before activating later
to cause further infections, referred to as relapses. As around 79-96$\%$ of
infections are attributed to relapses, we expect it will be highly impactful to
apply treatment to target the hypnozoite reservoir to eliminate \textit{P.
vivax}. Treatment with a radical cure to target the hypnozoite reservoir is a
potential tool to control or eliminate \textit{P. vivax}. We have developed a
multiscale mathematical model as a system of integro-differential equations
that captures the complex dynamics of \textit{P. vivax} hypnozoites and the
effect of hypnozoite relapse on disease transmission. Here, we use our model to
study the anticipated effect of radical cure treatment administered via a mass
drug administration (MDA) program. We implement multiple rounds of MDA with a
fixed interval between rounds, starting from different steady-state disease
prevalences. We then construct an optimisation model to obtain the optimal MDA
interval. We also incorporate mosquito seasonality in our model to study its
effect on the optimal treatment regime. We find that the effect of MDA
interventions is temporary and depends on the pre-intervention disease
prevalence (and choice of model parameters) as well as the number of MDA rounds
under consideration. We find radical cure alone may not be enough to lead to
\textit{P. vivax} elimination under our mathematical model (and choice of model
parameters) since the prevalence of infection eventually returns to pre-MDA
levels.
